Related Experiment Video

Updated: Feb 28, 2026

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.3K

Delayed progression of bull's eye maculopathy

Sunila Jain1, Neel Gautam Jain2

  • 1Ophthalmology, Royal Preston Hospital, Preston, UK.

BMJ Case Reports
|June 10, 2017
PubMed

Insights

Chloroquine maculopathy can worsen years after stopping the drug, even after visual stability. Patients and doctors must recognize the risk of delayed retinal toxicity and continue regular eye monitoring.

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Pharmacology

Background:

  • Chloroquine is a medication with known ocular toxicity.
  • Maculopathy is a disease affecting the macula, the central part of the retina.

Observation:

  • Chloroquine-induced maculopathy can exhibit delayed onset and progression.
  • Visual function may appear stable for years after drug cessation.

Findings:

  • Retinal toxicity from chloroquine may manifest or worsen long after the medication is stopped.
  • Progression of maculopathy can occur years after initial diagnosis and drug cessation.

Implications:

  • Ophthalmologists and patients need awareness of the potential for late-onset and progressive chloroquine maculopathy.
  • Continued regular ophthalmologic monitoring is essential for patients with a history of chloroquine use, even after apparent recovery.
Keywords:
Drugs: musculoskeletal and joint diseasesEye

More Related Videos

Iris Fixation via External Pentagram Suturing05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.9K
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.9K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K